|
Includes all of these presentations from this session:
| # |
Presentation |
Speaker |
| 1 |
Are criteria measuring response in esophageal cancer appropriate? |
B. Br?cher (Richmond, VA) |
| 2 |
What is the role of HPV in esophageal cancer? |
S. Rajendra (Sydney) |
| 3 |
How does HPV exert its oncogenic potential? |
Bin Wang (Sydney) |
| 4 |
How strong is the association between HPV and esophageal squamous cell carcinoma? |
R. Vajpeyi (Toronto) |
| 5 |
What is H. pylori role in cardiac carcinoma? |
H. El-Zimaity (Toronto) |
| 6 |
Does H.pylori eradication increase esophageal cancer incidence? |
G. Darling (Toronto) |
| 7 |
Does H. Pylori genotype influence esophageal cancer? |
H. El-Zimaity (Toronto) |
| 8 |
Does EBV infection have a role in esophageal cancer? |
S. Hafezi Bakhtiari (Toronto) |
| 9 |
Does bacterial infections influence mucin expression and cancer risk? |
C. Streutker (Toronto) |
| 10 |
Is there a role for esophageal bacterial biota in the incidence of esophageal disease? |
S. Al-Haddad (Toronto) |
| 11 |
What is the relationship between HIV infection and esophageal epithelial malignancies? |
A. Barbour (Brisbane) |
| 12 |
Would probiotics control the rising incidence of esophageal cancer? |
G. Soucy (Montreal) |
|
